下面抄自FDA 文件。
辉瑞
Available safety data from all participants enrolled through the November 14, 2020, data cut-off ( N=43,252, which includes late enrollment of additional adolescent and adultparticipants), was consistent with the safety profile for the approximately 38,000 ……
第39页表下注明：最后一个志愿者10月9日注射。
Participants >16 years of age enrolled by October 9, 2020。
https://www.fda.gov/media/144416/download
在大选前是无法被批准的。
Moderna COVID-19 Vaccine
https://www.fda.gov/media/144434/download
Efficacy data from the final scheduled analysis of the primary efficacy endpoint (data cutoff of November 21, 2020, with a median follow-up of >2 months post-dose 2) demonstrated a VE of 94.1% (95% CI 89.3%, 96.8%), with 11 COVID-1
辉瑞
Available safety data from all participants enrolled through the November 14, 2020, data cut-off ( N=43,252, which includes late enrollment of additional adolescent and adultparticipants), was consistent with the safety profile for the approximately 38,000 ……
第39页表下注明：最后一个志愿者10月9日注射。
Participants >16 years of age enrolled by October 9, 2020。
https://www.fda.gov/media/144416/download
在大选前是无法被批准的。
Moderna COVID-19 Vaccine
https://www.fda.gov/media/144434/download
Efficacy data from the final scheduled analysis of the primary efficacy endpoint (data cutoff of November 21, 2020, with a median follow-up of >2 months post-dose 2) demonstrated a VE of 94.1% (95% CI 89.3%, 96.8%), with 11 COVID-1
锟斤拷锟洁辑时锟斤拷: 2021-05-17 18:43:31
